Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge

Diane MajorNational Institute for Biological Standards and Control; Medicines and Healthcare Products Regulatory Agency; Potters Bar, UK

Jessica A ChichesterFraunhofer USA Center for Molecular Biotechnology; Newark, DE, USA

Rishi D PathiranaInfluenza Center; Department of Clinical Science; University of Bergen; Bergen, Norway;Department of Research & Development; Haukeland University Hospital; Bergen, Norway;K.G. Jebsen Center for Influenza Vaccine Research; University of Bergen; Bergen, Norway

Kate GuilfoyleNational Institute for Biological Standards and Control; Medicines and Healthcare Products Regulatory Agency; Potters Bar, UK

Yoko ShojiFraunhofer USA Center for Molecular Biotechnology; Newark, DE, USA

Carlos A GuzmanDepartment of Vaccinology and Applied Microbiology; Helmholtz Center for Infection Research; Braunschweig, Germany

Vidadi YusibovFraunhofer USA Center for Molecular Biotechnology; Newark, DE, USA

Rebecca J CoxInfluenza Center; Department of Clinical Science; University of Bergen; Bergen, Norway;Department of Research & Development; Haukeland University Hospital; Bergen, Norway;K.G. Jebsen Center for Influenza Vaccine Research; University of Bergen; Bergen, NorwayCorrespondence[email protected]

show all

Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date